Search - tctmd.com

Displaying 321 - 340 of 981

Sort: Relevancy | Date

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

News Daily News

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

L.A. McKeown

February 14, 2019

News Conference News STS 2019

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

Yael L. Maxwell

February 06, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Daily News

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

Todd Neale

January 30, 2019

News Conference News STS 2019

TAVR-Related Complications, High Resource Use Decreasing at a Surgeon-Led Program

Yael L. Maxwell

January 30, 2019

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

L.A. McKeown

January 21, 2019

News Daily News

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

Yael L. Maxwell

January 14, 2019

News Daily News

FDA Approves Pea-Sized Occluder for Patent Ductus Arteriosus in Premature Babies

L.A. McKeown

January 14, 2019

News Daily News

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

Caitlin E. Cox

January 04, 2019

News Daily News

FDA Clears Next-Generation Sapien 3 Ultra TAVR Valve

Todd Neale

January 02, 2019

News Features

Top News in Structural Heart Disease: 2018

L.A. McKeown

December 28, 2018

Manuscript

TAVR in Patients with Left Ventricular Assist Device: Case Report and Literature Review

December 21, 2018

News Daily News

Proposed Legislation Readies Another Arrow at the Medical Device Excise Tax

Yael L. Maxwell

December 11, 2018

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Conference News AHA 2018

Complications Following TAVR Are Going Down, US Data Show

Yael L. Maxwell

November 20, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

Advertisement

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

TCTMD’s Top 10 Most Popular Stories for January 2019

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

TAVR-Related Complications, High Resource Use Decreasing at a Surgeon-Led Program

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

FDA Approves Pea-Sized Occluder for Patent Ductus Arteriosus in Premature Babies

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

FDA Clears Next-Generation Sapien 3 Ultra TAVR Valve

Top News in Structural Heart Disease: 2018

TAVR in Patients with Left Ventricular Assist Device: Case Report and Literature Review

Proposed Legislation Readies Another Arrow at the Medical Device Excise Tax

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Complications Following TAVR Are Going Down, US Data Show

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content